@zenobiatherapeutics.com
Zenobia Therapeutics is a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allIcon
PNG
About
Description
Zenobia Therapeutics is a leading brand specializing in fragment-based lead discovery (FBLD) and the development of treatments for neurodegenerative diseases. Founded in 2008, Zenobia is dedicated to revolutionizing the field of drug discovery. Their products division, Zenobia Fragments, offers a wide range of products and services to support fragment-based lead discovery.
Zenobia's diverse collection of 967 highly core diverse fragments, known as the Fragment Library, is designed to meet their internal Guideline of Two. These fragments have been instrumental in the discovery of hits for various targets around the world. Additionally, Zenobia Fragments provides unique fragment-based reagents known as Fradditives for protein solubilization and crystallization.
Complimenting their product offerings, Zenobia Therapeutics also offers screening and structural biology services to enhance and support fragment library purchases. Their team of experts is committed to enabling researchers to make breakthroughs in CNS disease treatments. Discover the power of Zenobia Therapeutics and their innovative solutions for fragment-based lead discovery and neurodegenerative disease research.
Contact them today to learn more about their products and services
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online